Dhanuka Agritech Limited shareholders approved all seven resolutions at the company’s 41st Annual General Meeting (AGM) held on August 3, 2026, including critical equity incentive plans and director reappointments. The most significant outcomes were the approval of the Dhanuka Employee Stock Option Plan 2026 (ESOP 2026) and the Dhanuka Stock Appreciation Rights Plan 2026 (SAR 2026), both passed as special resolutions. These approvals enable the company to grant equity-linked incentives to eligible employees, aligning long-term employee interests with shareholder value creation despite notable dissent on the ESOP proposal from institutional investors.

The meeting, conducted via Video Conferencing (VC) in compliance with Ministry of Corporate Affairs (MCA) and Securities and Exchange Board of India (SEBI) circulars, commenced at 11:00 A.M. IST. A total of 95 members attended, satisfying the quorum under Section 103 of the Companies Act, 2013. Mahendra Kumar Dhanuka, Chairman, chaired the proceedings, while Rahul Dhanuka, Managing Director, welcomed attendees. The Audited Financial Statements for FY26, along with reports from the Board and Statutory Auditor M/s. S.S. Kothari Mehta & Company LLP, were adopted.

Voting Results and Shareholder Sentiment

The consolidated scrutinizer’s report by M/s. VAPN & Associates, dated August 4, 2026, details the voting patterns across all resolutions. While promoter group support was unanimous across all items, public institutional investors showed significant divergence on the ESOP plan. The remote e-voting facility was provided by National Securities Depositories Limited (NSDL), with voting open from July 31 to August 2, 2026.

Governance and Compliance Details

The AGM adhered to regulatory requirements under Section 108 of the Companies Act, 2013, Rule 20 of the Companies (Management and Administration) Rules, 2014, and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The cut-off date for voting eligibility was July 27, 2026, with 42,503 shareholders on record. The promoter group held 3,11,21,902 shares, representing approximately 69.8% of the total equity, and voted unanimously in favor of all resolutions.

Harsh Dhanuka and Ashish Saraf were reappointed as Executive Directors after retiring by rotation. The Board also sought ratification for the remuneration payable to the company’s Cost Auditors. Independent Directors Satish Kumar Gupta, Sanjay Saxena, Sanjiv Goel, Namrata Gupta, and Bajrang Lal Bajaj ensured robust oversight during the proceedings. The e-voting option remained open for 15 minutes post-meeting for members who had not yet voted.

What the Numbers Show

The voting data reveals a clear split in shareholder sentiment regarding employee compensation structures. While the SAR 2026 plan received near-universal support (98.86%), the ESOP 2026 plan faced substantial opposition from public institutions, which voted against it with 93.22% dissent. This suggests institutional investors may view stock options as more dilutive or less aligned with immediate performance metrics compared to stock appreciation rights. Conversely, the reappointment of Harsh Dhanuka saw minor dissent from public institutions (0.56% against), indicating specific concerns about individual director tenure or performance rather than a broad governance issue.

Dhanuka Agritech Limited reported a net profit of ₹36.30 crore for the quarter ended June 30, 2026 (Q1FY26), marking a 34.6% decline from the ₹55.50 crore recorded in the same period last year. Revenue from operations fell 12.6% to ₹461.93 crore, reflecting seasonal variations typical of the agrochemical sector. Despite the earnings contraction, the company’s Board of Directors approved significant strategic expansions, including a ₹200 crore pesticide manufacturing facility in Nagpur and a share buyback program worth ₹70 crore.

The financial results were reviewed by the Audit Committee and approved by the Board on August 3, 2026. S S Kothari Mehta & Co. LLP, the statutory auditors, conducted a limited review of the unaudited financial results pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were prepared in accordance with Ind AS 34 and other generally accepted accounting principles in India.

Financial Performance Overview

Revenue from operations stood at ₹46,192.81 lakh for Q1FY26, compared to ₹52,828.81 lakh in Q1FY25. Other income decreased to ₹886.28 lakh from ₹804.38 lakh in the prior year quarter. Total expenses were ₹42,221.73 lakh, up from ₹46,178.63 lakh in Q1FY25, primarily due to lower material costs which dropped to ₹28,713.26 lakh from ₹36,145.86 lakh. However, other expenses rose to ₹6,094.09 lakh from ₹6,046.20 lakh.

Basic Earnings Per Share (EPS) declined to ₹8.06 from ₹12.31 in the corresponding quarter of FY25. For the nine months ended March 31, 2026, the company reported a net profit of ₹287.23 crore on revenue of ₹2,019.79 crore.

Strategic Expansions and Capital Allocation

The Board approved an investment of up to ₹200 crore to establish a pesticide manufacturing unit in Nagpur, Maharashtra. The new plant will have a capacity of 23,000 MT per annum and is expected to be operational by March or April 2028. Financing will be sourced through internal accruals and/or debt. Management cited logistical advantages, reduced lead times to prime markets in South, East, and Central India, and favorable industrial policies in Maharashtra as key rationales for the expansion.

Additionally, the Board sanctioned a loan of up to ₹15 crore to the proposed Dhanuka Employee Stock Benefits Trust. The funds will be used for the acquisition of equity shares from the open market and the administration of the "Dhanuka Stock Appreciation Rights Plan, 2026" (SAR 2026), in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Share Buyback Impact

During the quarter, Dhanuka Agritech bought back 500,000 fully paid-up equity shares at ₹1,400 per share, aggregating to ₹70 crore. The shares were extinguished on June 20, 2026. This buyback represented 1.11% of the total issued and paid-up equity capital and resulted in a reduction of paid-up share capital by ₹10 lakh. The remaining paid-up equity share capital stands at ₹891.57 lakh.

What the Numbers Show

The divergence between revenue decline (-12.6%) and expense reduction (-8.8%) highlights margin pressure in Q1FY26. While cost of materials consumed fell significantly, helping cushion the bottom line, the overall profit decline was sharper than revenue, indicating fixed cost rigidity or lower operating leverage. The strategic move to build a local manufacturing capacity in Nagpur aims to mitigate long-term logistical costs and supply chain dependencies, potentially improving future margins despite short-term headwinds.